entertainment -WSS

entertainment

author：comprehensive 2025-10-06 17:35:37 - browse：1118

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： After John Oliver segment, STAT readers share their opioid

WSS

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

White House drug shortages task force keeps mum with Congress

Newly revealed memo details efforts to keep Trump in power following election loss

Genentech weighs delaying cancer therapy after drug pricing law

The drug industry sees a key ally in the Senate prevail

CDC overhauls leadership of center that led response to Covid

knowledge

entertainment

entertainment

Sports medicine is finally prioritizing gender equality

TytoCare raises $49 million to build out AI

The cancer drug shortage isn’t new — and neither are the solutions

'Ancient DNA,' 23andMe reveal African American ancestries

The high cost of giving birth even with insurance

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Moonlake's readout produced a cash windfall. Risks remain

Large hospital system sues Multiplan for low

Wildfire smoke exposes gaps in outdoor worker protections

White House drug shortage group privately met with industry

explore

GOP presidential candidates start declaring their loyalty

Timeline: Special counsel's investigation into Trump's handling of classified documents

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Dramatically reducing cancer deaths requires the PASTEUR Act

Maui funeral service workers on devastation of fires: 'I'm in shock'

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Wikipedia

focus

hotspot

explore